View as an RSS Feed
- JPMorgan Healthcare Conference 2014: Where To Find Ideas For The Coming Year
- Apple Earnings Preview: Guidance Achievable, Tim Cook Aims To Beat Expectations
- JPMorgan Healthcare Conference 2013: Ultra-Orphan Drug And Health IT Companies Lead The Way
- SandRidge Energy: Enormous Cash Generating Abilities Overlooked
- JP Morgan Healthcare Conference 2012: Insights From Jamie Dimon
- SandRidge Energy: Worries Regarding Future Capital Expenditures Overblown
- Clinical Data Inc.: Is $30 the Floor?
- JP Morgan Healthcare Conference 2011: 'Google Saves Lives'
- Las Vegas Sands: Consistently Misunderstood
- WellPoint May Replace Goldman as America’s Newest Punching Bag
- JP Morgan Healthcare Conference 2010: Speakers Address Reform
- Genzyme: Shire Chomping at the Bit
- The Odds Are Against Genzyme
Winds of Change: Harbingers of Correction Emerging
on Oct. 1, 2009 • 8 Comments
- Onyx Pharmaceuticals: Is Nexavar the Next Avastin?
- Plenty of Natural Gas: Exploration and Production Companies Keep Increasing Oversupply
- Onyx Pharmaceuticals: Good Reasons for Raising Capital, Investors Overly Concerned
- Housing Inventory Still High: Are There Enough Buyers and Savers?
- Why Inflation Worries Are Overblown
- Consider These Conditions When Using the Unemployment Rate as 'Any Kind' of Indicator